Bacteriolytic complex, method of its production, and strain for realization of the method

Abstract

The inventions relate to the field of medicine, veterinary and biotechnology and may be used for production of a drug for medical and veterinary purposes. A bacteriolytic complex, produced by the bacterium Lysobacter sp. XL1, has been proposed, which contains bacteriolytic enzymes (muramidase, muramoylalanineamidase, endopeptidase, a bacteriolytic enzyme with a molecular weight of about 22 kDa), protease, polysaccharide, and ballast components. The method of production of the bacteriolytic complex includes cultivation of the strain-producer on a nutrient medium containing glucose, peptone, yeast extract or yeast autolysate, phosphate salts of sodium and potassium, magnesium sulfate, potassium chloride, iron sulfate, and water.

1 - 3 . (canceled)  
   
   
       4 . A strain of bacterium  Lysobacter  sp. XL1 having been deposited in the All-Russian collection of microorganisms under accession number VKM B-2249 D.  
   
   
       5 . The strain according to  claim 4 , that produces a bacteriolytic complex including muramidase, muramoylalanineamidase, endopeptidase, protease, a polysaccharide and a bacteriolytic enzyme, wherein the bacteriolytic enzyme has a molecular mass of about 22 kDa.